The global HER2-positive gastric cancer market is on a promising growth trajectory, with a current valuation of USD 1,261.8 million in 2023. According to the latest market analysis, this sector is expected to expand at a compound annual growth rate (CAGR) of 3.5% over the next decade. By 2033, the market is projected to reach …